Oslo, Norway Norwegian Research Council is the famous Corporate Investor, which was founded in 1993. The leading representative office of defined Corporate Investor is situated in the Oslo. The company was established in Europe in Norway.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - Norway. Among the most popular portfolio startups of the fund, we may highlight Vaccibody. Among the most successful fund investment fields, there are Quantum Computing, Artificial Intelligence. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The high activity for fund was in 2019. Considering the real fund results, this Corporate Investor is 13 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 1 - 5 millions dollars.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Norwegian Research Council, startups are often financed by Birk Venture. The meaningful sponsors for the fund in investment in the same round are Lockheed Martin, EASME - EU Executive Agency for SMEs.
Related Funds
Funds with similar focus
| Fund Name | Location |
| AFCV Holdings | Missouri City, Texas, United States |
| Ashoka | Arlington, United States, Virginia |
| BDC IT Venture Fund | Canada, Ontario, Toronto |
| C.Domain Capital | Beijing, Beijing, China |
| Cavallo Consulting | California, Corona, United States |
| Circles & Squares | Central Denmark Region, Denmark, Randers |
| Fame Mount Limited | - |
| Fuhai Yintao | China, Guangdong, Shenzhen |
| Jiaxing Pucheng Gquan Touzi Hehuoqiye | China, Jiaxing, Zhejiang |
| Jumpstart New Jersey Angel Network | New Brunswick, New Jersey, United States |
| Kingson Capital Partners | Durban, KwaZulu-Natal, South Africa |
| Millville Opportunities Management | New York, New York, United States |
| PCCI | Dallas, Texas, United States |
| Redline Blockchain Capital | - |
| Savitr Capital | California, San Francisco, United States |
| Shefa Capital | Israel, Tel Aviv, Tel Aviv District |
| TechMinsk | Belarus, Minsk |
| Valquest Partners | Beirut, Beyrouth, Lebanon |
| Viva BioInnovator | China, Shanghai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Vaccibody | $864K | 21 Jun 2013 | Oslo, Norway |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Vaccibody | $864K | 21 Jun 2013 | Oslo, Norway |
